Analysis of Geographic Areas
Pfizer Inc. operates in 3 regions: United States; Developed Markets; and Emerging Markets.
Area Asset Turnover
Pfizer Inc., asset turnover by geographic area
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 3.97 | 2.64 | 4.63 | 3.55 | 2.78 |
| Developed Markets | 2.23 | 3.11 | 6.65 | 5.67 | 2.28 |
| Emerging Markets | 6.09 | 6.76 | 14.22 | 19.60 | 9.41 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
| Developed Markets | Developed Markets area asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. | |
| Emerging Markets | Emerging Markets area asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Area Asset Turnover: United States
Pfizer Inc.; United States; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 38,691) | 28,145) | 42,473) | 29,746) | 21,712) |
| Long-lived assets | 9,748) | 10,673) | 9,179) | 8,385) | 7,821) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 3.97 | 2.64 | 4.63 | 3.55 | 2.78 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 38,691 ÷ 9,748 = 3.97
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Area Asset Turnover: Developed Markets
Pfizer Inc.; Developed Markets; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 16,057) | 20,910) | 37,760) | 30,842) | 11,824) |
| Long-lived assets | 7,187) | 6,713) | 5,682) | 5,441) | 5,188) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 2.23 | 3.11 | 6.65 | 5.67 | 2.28 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 16,057 ÷ 7,187 = 2.23
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Developed Markets | Developed Markets area asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Area Asset Turnover: Emerging Markets
Pfizer Inc.; Emerging Markets; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 8,879) | 10,498) | 20,097) | 20,701) | 8,372) |
| Long-lived assets | 1,458) | 1,554) | 1,413) | 1,056) | 890) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 6.09 | 6.76 | 14.22 | 19.60 | 9.41 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 8,879 ÷ 1,458 = 6.09
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Emerging Markets | Emerging Markets area asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Long-lived assets
Pfizer Inc., long-lived assets by geographic area
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 9,748) | 10,673) | 9,179) | 8,385) | 7,821) |
| Developed Markets | 7,187) | 6,713) | 5,682) | 5,441) | 5,188) |
| Emerging Markets | 1,458) | 1,554) | 1,413) | 1,056) | 890) |
| Total | 18,393) | 18,940) | 16,274) | 14,882) | 13,899) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Revenues
Pfizer Inc., revenues by geographic area
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 38,691) | 28,145) | 42,473) | 29,746) | 21,712) |
| Developed Markets | 16,057) | 20,910) | 37,760) | 30,842) | 11,824) |
| Emerging Markets | 8,879) | 10,498) | 20,097) | 20,701) | 8,372) |
| Total | 63,627) | 59,553) | 100,330) | 81,289) | 41,908) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).